Publication | Closed Access
Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
43
Citations
55
References
2020
Year
InflammationCytokineNovel Selective InhibitorAnti-inflammatoryAutoimmune DiseaseMedicinePreclinical CharacterizationImmunologyInflammatory DiseasesPharmacotherapyImmunotherapyPharmacologyInflammatory DiseaseNovel TherapyDrug DiscoveryJak-stat Signaling Pathway
| Year | Citations | |
|---|---|---|
Page 1
Page 1